Jay Bhattacharya

Jay Bhattacharya

physician United States

Dr. Jay Bhattacharya is a physician and health policy researcher known for his controversial views on public health measures during the COVID-19 pandemic. He was one of the panelists on the Alberta task force that recommended a halt to COVID-19 vaccines, and he co-authored the Great Barrington Declaration, which criticized lockdowns and other public health interventions.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

United States United States: NIH Director Dr. Jay Bhattacharya joins 'America's Newsroom' to discuss the Trump administration's crackdown on doctors providing gender surgeries on underage patients. 6

Fox News: Federal judge strikes down California school gender identity policy

United States United States: National Institutes of Health Director Dr. Jay Bhattacharya stated that the agency will end support for research into gender transition. 4

CNN: Trump moves to ban transgender care for minors by targeting hospitals

Canada Canada: Jay Bhattacharya is the director of the U.S. National Institutes of Health and was present during the announcement of the policy change. 4

The Globe and Mail: COVID-19 vaccination lowers risks during pregnancy, UBC study finds

Canada Canada: Jay Bhattacharya, director of the U.S. National Institutes of Health, was present during the announcement of the policy change regarding COVID vaccinations. 5

The Globe and Mail: Quebec’s outgoing public-health director hopeful there will be enough free COVID-19 shots to go around

Switzerland Switzerland: NIH chief Jay Bhattacharya announced a new research initiative to explore the causes of autism. 5

Neue Zürcher Zeitung: Autismus-Risiko durch Schmerzmittel? Trumps Warnung vor Tylenol

United States United States: National Institutes of Health (NIH) Director Jay Bhattacharya discussed research suggesting that leucovorin is effective in off-label use for children with autism. 7

Fox News: Cancer drug leucovorin may show promise for autism treatment, administration officials say